576 related articles for article (PubMed ID: 24239568)
1. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases.
Spite M; Clària J; Serhan CN
Cell Metab; 2014 Jan; 19(1):21-36. PubMed ID: 24239568
[TBL] [Abstract][Full Text] [Related]
2. Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases.
Tang S; Wan M; Huang W; Stanton RC; Xu Y
Mediators Inflamm; 2018; 2018():2380319. PubMed ID: 29674943
[TBL] [Abstract][Full Text] [Related]
3. Resolvins: Emerging Players in Autoimmune and Inflammatory Diseases.
Abdolmaleki F; Kovanen PT; Mardani R; Gheibi-Hayat SM; Bo S; Sahebkar A
Clin Rev Allergy Immunol; 2020 Feb; 58(1):82-91. PubMed ID: 31267470
[TBL] [Abstract][Full Text] [Related]
4. Lipid mediators in the resolution of inflammation.
Serhan CN; Chiang N; Dalli J; Levy BD
Cold Spring Harb Perspect Biol; 2014 Oct; 7(2):a016311. PubMed ID: 25359497
[TBL] [Abstract][Full Text] [Related]
5. Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders.
Han YH; Lee K; Saha A; Han J; Choi H; Noh M; Lee YH; Lee MO
Biomol Ther (Seoul); 2021 Sep; 29(5):455-464. PubMed ID: 34162770
[TBL] [Abstract][Full Text] [Related]
6. The roles of special proresolving mediators in pain relief.
Zhang LY; Jia MR; Sun T
Rev Neurosci; 2018 Aug; 29(6):645-660. PubMed ID: 29420307
[TBL] [Abstract][Full Text] [Related]
7. Resolution of inflammation in oral diseases.
Eltay EG; Van Dyke T
Pharmacol Ther; 2023 Jul; 247():108453. PubMed ID: 37244405
[TBL] [Abstract][Full Text] [Related]
8. Leukocytes from obese individuals exhibit an impaired SPM signature.
López-Vicario C; Titos E; Walker ME; Alcaraz-Quiles J; Casulleras M; Durán-Güell M; Flores-Costa R; Pérez-Romero N; Forné M; Dalli J; Clària J
FASEB J; 2019 Jun; 33(6):7072-7083. PubMed ID: 30840838
[TBL] [Abstract][Full Text] [Related]
9. Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages.
Croasdell A; Thatcher TH; Kottmann RM; Colas RA; Dalli J; Serhan CN; Sime PJ; Phipps RP
Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L888-901. PubMed ID: 26301452
[TBL] [Abstract][Full Text] [Related]
10. Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications.
Valente M; Dentoni M; Bellizzi F; Kuris F; Gigli GL
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956787
[TBL] [Abstract][Full Text] [Related]
11. Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicines.
Arnardottir HH; Dalli J; Colas RA; Shinohara M; Serhan CN
J Immunol; 2014 Oct; 193(8):4235-44. PubMed ID: 25217168
[TBL] [Abstract][Full Text] [Related]
12. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.
Serhan CN
FASEB J; 2017 Apr; 31(4):1273-1288. PubMed ID: 28087575
[TBL] [Abstract][Full Text] [Related]
13. Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases.
Perucci LO; Sugimoto MA; Gomes KB; Dusse LM; Teixeira MM; Sousa LP
Expert Opin Ther Targets; 2017 Sep; 21(9):879-896. PubMed ID: 28786708
[TBL] [Abstract][Full Text] [Related]
14. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution.
Fredman G; Serhan CN
Biochem J; 2011 Jul; 437(2):185-97. PubMed ID: 21711247
[TBL] [Abstract][Full Text] [Related]
15. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.
Chiang N; Serhan CN
Mol Aspects Med; 2017 Dec; 58():114-129. PubMed ID: 28336292
[TBL] [Abstract][Full Text] [Related]
16. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.
Kotlyarov S; Kotlyarova A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563200
[TBL] [Abstract][Full Text] [Related]
17. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
Serhan CN; de la Rosa X; Jouvene C
J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
[TBL] [Abstract][Full Text] [Related]
18. Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma.
Kytikova O; Novgorodtseva T; Denisenko Y; Antonyuk M; Gvozdenko T
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31216723
[TBL] [Abstract][Full Text] [Related]
19. Major structure-activity relationships of resolvins, protectins, maresins and their analogues.
Daly K; O'Sullivan K; O'Sullivan TP
Future Med Chem; 2022 Dec; 14(24):1943-1960. PubMed ID: 36449363
[TBL] [Abstract][Full Text] [Related]
20. n-3 Fatty acid supplementation and proresolving mediators of inflammation.
Barden AE; Mas E; Mori TA
Curr Opin Lipidol; 2016 Feb; 27(1):26-32. PubMed ID: 26655290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
